MORGAN STANLEY PLC/CALL/STRYKER CORP./440/0.1/20.09.24 Share Price

Warrant

DE000ME17RH5

Market Closed - Börse Stuttgart 09:34:53 17/05/2024 pm IST
0.097 EUR -1.02% Intraday chart for MORGAN STANLEY PLC/CALL/STRYKER CORP./440/0.1/20.09.24
Current month-28.15%
1 month-39.38%
Date Price Change
17/24/17 0.097 -1.02%
16/24/16 0.098 +4.26%
15/24/15 0.094 -2.08%
14/24/14 0.096 -2.04%
13/24/13 0.098 -7.55%

Delayed Quote Börse Stuttgart

Last update May 17, 2024 at 09:34 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying STRYKER CORPORATION
Issuer Morgan Stanley
WKN ME17RH
ISINDE000ME17RH5
Date issued 27/09/2023
Strike 440 $
Maturity 20/09/2024 (124 Days)
Parity 10 : 1
Emission price 0.18
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.46
Lowest since issue 0.02
Spread 0.036
Spread %27.07%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
334.7 USD
Average target price
372.4 USD
Spread / Average Target
+11.26%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW